The role of lipids in Parkinson's disease

H Xicoy, B Wieringa, GJM Martens - Cells, 2019 - mdpi.com
Parkinson's disease (PD) is a neurodegenerative disease characterized by a progressive
loss of dopaminergic neurons from the nigrostriatal pathway, formation of Lewy bodies, and …

Brain cannabinoid receptor 2: expression, function and modulation

DJ Chen, M Gao, FF Gao, QX Su, J Wu - Acta Pharmacologica Sinica, 2017 - nature.com
Cannabis sativa (marijuana) is a fibrous flowering plant that produces an abundant variety of
molecules, some with psychoactive effects. At least 4% of the world's adult population uses …

European Pain Federation (EFIC) position paper on appropriate use of cannabis‐based medicines and medical cannabis for chronic pain management

W Häuser, DP Finn, E Kalso… - … Journal of Pain, 2018 - Wiley Online Library
Cannabis‐based medicines are being approved for pain management in an increasing
number of European countries. There are uncertainties and controversies on the role and …

New insights and potential therapeutic targeting of CB2 cannabinoid receptors in CNS disorders

BG Kibret, H Ishiguro, Y Horiuchi, ES Onaivi - International journal of …, 2022 - mdpi.com
The endocannabinoid system (ECS) is ubiquitous in most human tissues, and involved in
the regulation of mental health. Consequently, its dysregulation is associated with …

Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone …

H Javed, S Azimullah, ME Haque… - Frontiers in neuroscience, 2016 - frontiersin.org
The cannabinoid type two receptors (CB2), an important component of the endocannabinoid
system, have recently emerged as neuromodulators and therapeutic targets for …

Cannabinoids and pain: sites and mechanisms of action

K Starowicz, DP Finn - Advances in Pharmacology, 2017 - Elsevier
The endocannabinoid system, consisting of the cannabinoid 1 receptor (CB 1 R) and
cannabinoid 2 receptor (CB 2 R), endogenous cannabinoid ligands (endocannabinoids) …

The cannabinoid system and microglia in health and disease

SS Duffy, JP Hayes, NT Fiore, G Moalem-Taylor - Neuropharmacology, 2021 - Elsevier
Recent years have yielded significant advances in our understanding of microglia, the
immune cells of the central nervous system (CNS). Microglia are key players in CNS …

Lipidomics of bioactive lipids in Alzheimer's and Parkinson's diseases: Where are we?

V Chiurchiù, M Tiberi, A Matteocci, F Fazio… - International Journal of …, 2022 - mdpi.com
Lipids are not only constituents of cellular membranes, but they are also key signaling
mediators, thus acting as “bioactive lipids”. Among the prominent roles exerted by bioactive …

Neurotransmitter receptors on microglia

H Liu, RK Leak, X Hu - Stroke and vascular neurology, 2016 - svn.bmj.com
As the resident immune cells in the central nervous system, microglia have long been
hypothesised to promote neuroinflammation and exacerbate neurotoxicity. However, this …

[HTML][HTML] The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases

V Chiurchiù, M van der Stelt, D Centonze… - Progress in …, 2018 - Elsevier
Multiple sclerosis is the most common inflammatory demyelinating disease of the central
nervous system, caused by an autoimmune response against myelin that eventually leads to …